146 ePosters
Gallery Display- Onsite Oral and Gallery PDF
Filtered By
- Onsite Oral and Gallery PDF
Sort By
ONSITE SYMPOSIUM: AD, PD, LBD, BIOMARKERS, DIAGNOSIS, IMAGING & CLINICAL TRIALS
ATTITUDES OF NEUROLOGISTS TOWARDS THE USE OF BIOMARKERS IN THE DIAGNOSIS OF EARLY-STAGE ALZHEIMER'S DISEASE (ID 3092)
Presenter
Authors
Session Name
0580 - ONSITE SYMPOSIUM: AD, PD, LBD, BIOMARKERS, DIAGNOSIS, IMAGING & CLINICAL TRIALS (ID 466)
PHOSPHORYLATED-PSD95 AS A MECHANISM-BASED BIOMARKER FOR SYNAPSE DYSFUNCTION IN SPORADIC ALZHEIMER’S DISEASE (ID 3054)
Session Name
0580 - ONSITE SYMPOSIUM: AD, PD, LBD, BIOMARKERS, DIAGNOSIS, IMAGING & CLINICAL TRIALS (ID 466)
STEPWISE FUNCTIONAL AND STRUCTURAL CONNECTIVITY REVEALS NETWORK REORGANIZATION IN ALZHEIMER’S DISEASE (ID 3055)
Presenter
Authors
Session Name
0580 - ONSITE SYMPOSIUM: AD, PD, LBD, BIOMARKERS, DIAGNOSIS, IMAGING & CLINICAL TRIALS (ID 466)
SOCIAL INTEGRATION IS ASSOCIATED WITH INCREASED CORTICAL THICKNESS AND GREY MATTER DENSITY (ID 3056)
Session Name
0580 - ONSITE SYMPOSIUM: AD, PD, LBD, BIOMARKERS, DIAGNOSIS, IMAGING & CLINICAL TRIALS (ID 466)
DECREASE IN MYELIN IS ASSOCIATED WITH FASTER TAU-PET ACCUMULATION AND COGNITIVE DECLINE IN ALZHEIMER’S DISEASE (ID 3057)
Presenter
Authors
Session Name
0580 - ONSITE SYMPOSIUM: AD, PD, LBD, BIOMARKERS, DIAGNOSIS, IMAGING & CLINICAL TRIALS (ID 466)
INCREASED ANTERIOR-TEMPORAL FUNCTIONAL CONNECTIVITY AS A POTENTIAL BIOMARKER FOR ALZHEIMER’S DISEASE (ID 3058)
Presenter
Authors
Session Name
0580 - ONSITE SYMPOSIUM: AD, PD, LBD, BIOMARKERS, DIAGNOSIS, IMAGING & CLINICAL TRIALS (ID 466)
PROTEIN DISULFIDE ISOMERASES AS CSF BIOMARKERS FOR THE EARLY NEURONAL RESPONSE TO TAU PATHOLOGY (ID 3059)
Presenter
Authors
Session Name
0580 - ONSITE SYMPOSIUM: AD, PD, LBD, BIOMARKERS, DIAGNOSIS, IMAGING & CLINICAL TRIALS (ID 466)
CORTICAL AMYLOID PREDICTS LONGITUDINAL ATROPHY IN NON-DEMENTED INDIVIDUALS: RESULTS FROM THE AMYPAD PROGNOSTIC STUDY (ID 3060)
Presenter
Authors
Session Name
0580 - ONSITE SYMPOSIUM: AD, PD, LBD, BIOMARKERS, DIAGNOSIS, IMAGING & CLINICAL TRIALS (ID 466)
ONSITE SYMPOSIUM: ALPHA-SYNUCLEIN, PATHOPHYSIOLOGY: AGGREGATION AND SEEDING
IMPACT OF Α-SYNUCLEIN PATHOLOGY ON CORTICOSTRIATAL SYNAPSES IN PARKINSON’S DISEASE (ID 2866)
Session Name
0310 - ONSITE SYMPOSIUM: ALPHA-SYNUCLEIN, PATHOPHYSIOLOGY: AGGREGATION AND SEEDING (ID 439)
PATHOLOGIC EXCESS OF SOLUBLE ALPHA-SYNUCLEIN MONOMERS ASSOCIATES WITH SLOWING OF MOVEMENT IN NOVEL TETRAMER-ABOLISHING MOUSE MODELS OF PD AND GAUCHER’S PD (ID 2867)
Presenter
Session Name
0310 - ONSITE SYMPOSIUM: ALPHA-SYNUCLEIN, PATHOPHYSIOLOGY: AGGREGATION AND SEEDING (ID 439)
DISTINCT CONFORMATIONAL STRAINS OF ALPHA-SYNUCLEIN AGGREGATES CAN FORM IN IDENTICAL EXPERIMENTAL CONDITIONS (ID 2869)
Presenter
Authors
Session Name
0310 - ONSITE SYMPOSIUM: ALPHA-SYNUCLEIN, PATHOPHYSIOLOGY: AGGREGATION AND SEEDING (ID 439)
TOXICITY OF EXTRACELLULAR ALPHA-SYNUCLEIN IS INDEPENDENT OF INTRACELLULAR ALPHA-SYNUCLEIN (ID 2872)
Presenter
Session Name
0310 - ONSITE SYMPOSIUM: ALPHA-SYNUCLEIN, PATHOPHYSIOLOGY: AGGREGATION AND SEEDING (ID 439)